Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

New Broadway Extravaganza Raises Funds for Chronic Neuro-Immune Disease Awareness Week
  • USA - English


News provided by

Brown Paper Tickets

Apr 24, 2015, 01:05 ET

Share this article

Share toX

Share this article

Share toX


We’ll be performing some of the boldest, most scene-stealing music we know, from the heart-wrenching to the hilarious. It’s going to be a wild night of wonderful music for a fabulous cause.

Post this

Vancouver, BC (PRWEB) April 23, 2015 -- This May, the critically acclaimed performers of Opera Mariposa are bringing audiences a night of musical theatre showstoppers in support of chronic neuro-immune disease awareness. On Saturday, May 16th, sopranos Jacqueline Ko and Robin Eder-Warren, baritenor Kyle Preston Oliver and pianist Chris Feige will present 'Tour de Force,' a Broadway benefit show at Marpole United Church. The performance will honour the International Awareness Week for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Fibromyalgia (ME/CFS & FM), and a portion of every ticket sale will go to the National ME/FM Action Network. Tickets start at $15 and are available at operamariposa.com or from Brown Paper Tickets at 1-800-838-3006.

Opera Mariposa's artistic director Jacqueline Ko has suffered from ME/CFS since the age of six, and she is determined to use her passion for music to raise awareness. "ME/CFS affects more than twenty-eight million people worldwide," Ko says, "and studies report that it can be as debilitating as lupus or late-stage AIDS. Despite this, many cases go undiagnosed, and patients struggle with not only the devastating symptoms, but a lack of medical support and community understanding."

Despite the challenges of her illness, Ko has managed to become a celebrated singer and show producer. At age 20 she teamed up with her childhood friend Robin Eder-Warren to found Opera Mariposa, an acclaimed Vancouver company for emerging artists, and now the young women are determined to use their success to help others. With 'Tour de Force,' Opera Mariposa will present their biggest Broadway show ever, featuring hits songs from 'Wicked,' 'Gypsy,' 'Spamalot,' 'Sweeney Todd' and more. "We're pulling out all the stops for this show," says Eder-Warren, "and we’ll be performing some of the boldest, most scene-stealing music we know, from the heart-wrenching to the hilarious. We have showstoppers from Sondheim, Bernstein and Lloyd Webber, as well as tributes to some of the great Broadway performers we love. It’s going to be a wild night of wonderful music for a fabulous cause."

The evening will include a prize raffle and reception, and the charitable proceeds will go towards educating more medical professionals in how to diagnose and treat ME/CFS and FM. 'Tour de Force' will be Mariposa's third benefit and awareness show; in 2013, their gala concert 'The Singer' raised $10,000 for the newly opened Complex Chronic Diseases Program at BC Women's Hospital, while their 2014 revue show 'The Butterfly' raised over $13,000 for the cause.

-30-

TOUR DE FORCE – Saturday, May 16th, 2015 at 7:30 pm
Marpole United Church, 1296 West 67th Avenue, Vancouver
$22 General | $18 Students/Seniors/Disability Benefit | $15 Groups of 4+
Tickets at the door, at operamariposa.com or from Brown Paper Tickets at 1-800-838-3006.

About Opera Mariposa: Opera Mariposa is a critically acclaimed Vancouver company run by young artists, for young artists. Now in their third season, they are dedicated to creating a stage for emerging talent, showcasing North America's most promising performers in a diverse program of gala concerts, original shows and fully staged opera productions. The Vancouver Project recently declared that "Opera Mariposa stands at the forefront of Vancouver's opera scene," and Mariposa's productions have been hailed as "a stroke of genius" (The Voice) for their ability to engage both dedicated music lovers and new audiences. Learn more at operamariposa.com

About the National ME/FM Action Network: The National ME/FM Action Network is a registered Canadian charity dedicated to advancing the recognition and understanding of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Fibromyalgia through support, advocacy, education and research. Some of their accomplishments include spearheading the development of the Consensus Documents, known as the Canadian Consensus Criteria, and providing information to patients, health professionals and educators. The network celebrated its 20th anniversary in 2013. Learn more at http://www.mefmaction.com

EDITOR'S NOTE: High-resolution photos are available. If you would like to schedule an interview with Jacqueline Ko or the other performers, please email Robin Eder-Warren at operamariposa(at)gmail(dot)com or call her at 778-918-9498. Opera Mariposa artists are also available to perform in-studio, as a way to provide you with a unique angle for covering Awareness Week and Opera Mariposa's third annual Awareness performance 'Tour de Force.'

Media contact: Robin Eder-Warren (Managing Director, Opera Mariposa)
778-918-9498 ▪ operamariposa(at)gmail(dot)com ▪ operamariposa.com

Barb Morgen, Brown Paper Tickets, http://www.brownpapertickets.com, +1 206-883-9093, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.